Positives

• One trial participant reported that after a few months “I was able to whisper briefly but reliably to my caregiver, which was extraordinary after years of silence” The Sick Times.
  
  

Negatives

• A reader shared “My son’s lipids went up as well. And no appreciable improvement in symptoms” after off-label rapamycin trialing, echoing reports of non-responders even when about half of patients improve Health Rising.
• One Phoenix Rising member ran rapamycin for three months at doses ranging 3 mg/week to 17 mg every two weeks and reported it “did nothing” for ME but caused dose-dependent depression that lifted after discontinuation Phoenix Rising.

Hurdles & Side Effects

• Rapamycin (sirolimus) is FDA-approved for organ transplant rejection, so off-label prescribing for ME/CFS or Long COVID typically requires a longevity-medicine clinician and out-of-pocket payment of roughly $200-400/month at compounded doses ME Association.